ARKG vs BIV
ARK Genomic Revolution ETF vs Vanguard Intermediate-Term Bond ETF
ARKG—
ARK Genomic Revolution ETF
Companies advancing genomics and molecular biology.
Expense: —Yield: —
BIV—
Vanguard Intermediate-Term Bond ETF
Intermediate-term investment-grade bonds.
Expense: —Yield: —
Side-by-side metrics
| Metric | ARKG | BIV |
|---|---|---|
Expense ratio Annual fee. Lower is better. | — | — |
Dividend yield Trailing 12-month yield. | — | — |
AUM Assets under management — bigger funds are typically more liquid. | — | — |
YTD return | — | — |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | — | — |
P/E ratio | — | — |
Last price | — | — |
Inception | — | — |
Issuer | ARK | Vanguard |
ARKG top holdings
Holdings data unavailable for ARKG.
BIV top holdings
Holdings data unavailable for BIV.
About ARKG
ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology.
About BIV
BIV (Vanguard Intermediate-Term Bond ETF) is Intermediate-term investment-grade bonds.